<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38961833</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population.</ArticleTitle><Pagination><StartPage>2188</StartPage><EndPage>2200</EndPage><MedlinePgn>2188-2200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.52139</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To reveal the clinical features and assess risk factors linked to brain fog and its societal implications, including labor productivity, providing valuable insights for the future care of individuals who have experienced coronavirus disease 2019 (COVID-19).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed a comprehensive cohort dataset comprising 1,009 patients with COVID-19 admitted to Japanese hospitals. To assess brain fog, we analyzed patients who responded to a questionnaire indicating symptoms such as memory impairment and poor concentration.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of brain fog symptoms decreased 3&#x2009;months posthospitalization but remained stable up to 12&#x2009;months. Neurological symptoms such as taste and smell disorders and numbness at hospitalization correlated with a higher frequency of identifying brain fog as a long COVID manifestation. Our findings indicated that advanced age, female sex, a high body mass index, oxygen required during hospitalization, chronic obstructive pulmonary disease, asthma, and elevated C-reactive protein and elevated D-dimer levels were risk factors in patients exhibiting brain fog. Additionally, we demonstrated the negative impact of brain fog on labor productivity by presenteeism scores.</AbstractText><AbstractText Label="INTERPRETATIONS" NlmCategory="CONCLUSIONS">This study clarified the clinical characteristics of patients experiencing brain fog as a long COVID manifestation, specifically emphasizing neurological symptoms during hospitalization and their correlation with brain fog. Additionally, the study identified associated risk factors for its onset and revealed that the emergence of brain fog was linked to a decline in labor productivity.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shigematsu</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Ryusei</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terai</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1118-1930</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mimura</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Physiology/Memory Center, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bun</LastName><ForeName>Shogyoku</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Namkoong</LastName><ForeName>Ho</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asakura</LastName><ForeName>Takanori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine (Laboratory of Bioregulatory Medicine), Kitasato University School of Pharmacy, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chubachi</LastName><ForeName>Shotaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masaki</LastName><ForeName>Katsunori</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohgino</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyata</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawada</LastName><ForeName>Ichiro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishii</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takemura</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueda</LastName><ForeName>Soichiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Saitama Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshiyama</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokuto</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusumoto</LastName><ForeName>Tatsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oashi</LastName><ForeName>Ayano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyawaki</LastName><ForeName>Masayoshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Fumitake</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tani</LastName><ForeName>Tetsuo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishioka</LastName><ForeName>Kota</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Saeko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Morio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, NHO Kanagawa National Hospital, Hatano, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Yasunori</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukunaga</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP 21fk0108431</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP 21fk0108553</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP 21fk0108563</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP 21fk0108573</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP 22fk0108510</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP 22fk0108513</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP 22fk0108573</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP 22wm0325031</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP20fk0108415</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP20fk0108452</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JP20nk0101612</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>20CA2054</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant><Grant><GrantID>JPMH21HA2011</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant><Grant><GrantID>JPMH23HA2011</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant><Grant><GrantID>JPMJCR20H2</GrantID><Agency>Core Research for Evolutional Science and Technology</Agency><Country/></Grant><Grant><GrantID>JPMJPR21R7</GrantID><Agency>Precursory Research for Embryonic Science and Technology</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000711647">long COVID brain fog</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000095225" MajorTopicYN="N">East Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005222" MajorTopicYN="Y">Mental Fatigue</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The corresponding authors have no conflicts of interest related to this manuscript to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>18</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>4</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38961833</ArticleId><ArticleId IdType="pmc">PMC11330230</ArticleId><ArticleId IdType="doi">10.1002/acn3.52139</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li X, Cui W, Zhang F. Who was the first doctor to report the COVID&#x2010;19 outbreak in Wuhan, China? J Nucl Med. 2020;61(6):782&#x2010;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262218</ArticleId><ArticleId IdType="pubmed">32303602</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID&#x2010;19 rapid guideline: managing the long&#x2010;term effects of COVID&#x2010;19. London. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C&#x2010;P&#x2010;ACSG. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324(6):603&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et&#xa0;al. Multiorgan impairment in low&#x2010;risk individuals with post&#x2010;COVID&#x2010;19 syndrome: a prospective, community&#x2010;based study. BMJ Open. 2021;11(3):e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al&#x2010;Aly Z. Postacute sequelae of COVID&#x2010;19 at 2&#x2009;years. Nat Med. 2023;29(9):2347&#x2010;2357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et&#xa0;al. Short&#x2010;term and long&#x2010;term rates of postacute sequelae of SARS&#x2010;CoV&#x2010;2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentilotti E, Gorska A, Tami A, et&#xa0;al. Clinical phenotypes and quality of life to define post&#x2010;COVID&#x2010;19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. 2023;62:102107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10466236</ArticleId><ArticleId IdType="pubmed">37654668</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Author correction: Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(6):408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10408714</ArticleId><ArticleId IdType="pubmed">37069455</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhirter L, Smyth H, Hoeritzauer I, Couturier A, Stone J, Carson AJ. What is brain fog? J Neurol Neurosurg Psychiatry. 2023;94(4):321&#x2010;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">36600580</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikura T, Nakano T, Kitano T, Tokuda T, Sumi&#x2010;Akamaru H, Naka T. Serum ferritin level during hospitalization is associated with brain fog after COVID&#x2010;19. Sci Rep. 2023;13(1):13095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10421912</ArticleId><ArticleId IdType="pubmed">37567939</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam GY, Damant RW, Ferrara G, et&#xa0;al. Characterizing long&#x2010;COVID brain fog: a retrospective cohort study. J Neurol. 2023;270(10):4640&#x2010;4646.</Citation><ArticleIdList><ArticleId IdType="pubmed">37555926</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Skorniewska Z, Hampshire A, et&#xa0;al. Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID&#x2010;19 hospitalization. Nat Med. 2023;29(10):2498&#x2010;2508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10579097</ArticleId><ArticleId IdType="pubmed">37653345</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz&#x2010;Luces JR, Aceituno H, Quiroz&#x2010;Bravo F, et&#xa0;al. Long&#x2010;lasting brain fog is related with severity clusters of symptoms in COVID&#x2010;19 patients. Rev Med Chile. 2022;150(11):1484&#x2010;1492.</Citation><ArticleIdList><ArticleId IdType="pubmed">37358174</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta S, Cristillo V, Camera G, et&#xa0;al. Incidence and Long&#x2010;term functional outcome of neurologic disorders in hospitalized patients with COVID&#x2010;19 infected with pre&#x2010;omicron variants. Neurology. 2023;101(9):e892&#x2010;e903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10501088</ArticleId><ArticleId IdType="pubmed">37414564</ArticleId></ArticleIdList></Reference><Reference><Citation>Largent J, Xie Y, Knuth KB, et&#xa0;al. Cognitive and other neuropsychiatric symptoms in COVID&#x2010;19: analysis of person&#x2010;generated longitudinal health data from a community&#x2010;based registry. BMJ Open. 2023;13(6):e069118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10314461</ArticleId><ArticleId IdType="pubmed">37336535</ArticleId></ArticleIdList></Reference><Reference><Citation>Imoto W, Yamada K, Kawai R, et&#xa0;al. A cross&#x2010;sectional, multicenter survey of the prevalence and risk factors for Long COVID. Sci Rep. 2022;12(1):22413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9793373</ArticleId><ArticleId IdType="pubmed">36575200</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Yang D, Lewis A, et&#xa0;al. A prospective study of long&#x2010;term outcomes among hospitalized COVID&#x2010;19 patients with and without neurological complications. J Neurol Sci. 2021;426:117486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, et&#xa0;al. Fatigue and cognitive impairment in post&#x2010;COVID&#x2010;19 syndrome: a systematic review and meta&#x2010;analysis. Brain Behav Immun. 2022;101:93&#x2010;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Adingupu DD, Soroush A, Hansen A, Twomey R, Dunn JF. Brain hypoxia, neurocognitive impairment, and quality of life in people post&#x2010;COVID&#x2010;19. J Neurol. 2023;270(7):3303&#x2010;3314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10200033</ArticleId><ArticleId IdType="pubmed">37210689</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N, Zhao YM, Yan W, et&#xa0;al. A systematic review and meta&#x2010;analysis of long term physical and mental sequelae of COVID&#x2010;19 pandemic: call for research priority and action. Mol Psychiatry. 2023;28(1):423&#x2010;433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M, Babicki M, Kapusta J, et&#xa0;al. Long&#x2010;COVID clinical features and risk factors: a retrospective analysis of patients from the STOP&#x2010;COVID registry of the PoLoCOV study. Viruses. 2022;14(8):1755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9415629</ArticleId><ArticleId IdType="pubmed">36016376</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi&#x2010;Pooya AA, Akbari A, Emami A, et&#xa0;al. Long COVID syndrome&#x2010;associated brain fog. J Med Virol. 2022;94(3):979&#x2010;984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson A, Mohamed MS, Moulin TC, Schioth HB. Neurological manifestations of COVID&#x2010;19: a comprehensive literature review and discussion of mechanisms. J Neuroimmunol. 2021;358:577658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8272134</ArticleId><ArticleId IdType="pubmed">34304141</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to Long COVID. Med Sci Monit. 2021;27:e931447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924007</ArticleId><ArticleId IdType="pubmed">33633106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocon AJ. Caught in the thickness of brain fog: exploring the cognitive symptoms of chronic fatigue syndrome. Front Physiol. 2013;4:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617392</ArticleId><ArticleId IdType="pubmed">23576989</ArticleId></ArticleIdList></Reference><Reference><Citation>Callan C, Ladds E, Husain L, Pattinson K, Greenhalgh T. I can't cope with multiple inputs': a qualitative study of the lived experience of &#x2018;brain fog&#x2019; after COVID&#x2010;19. BMJ Open. 2022;12(2):e056366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8844964</ArticleId><ArticleId IdType="pubmed">35149572</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Quach TC, Tiwari A, et&#xa0;al. Myalgic encephalomyelitis/chronic fatigue syndrome is common in post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2 infection (PASC): results from a post&#x2010;COVID&#x2010;19 multidisciplinary clinic. Front Neurol. 2023;14:1090747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawara K, Namkoong H, Terai H, et&#xa0;al. Comprehensive and long&#x2010;term surveys of COVID&#x2010;19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol. BMJ Open Respir Res. 2021;8(1):e001015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8628335</ArticleId><ArticleId IdType="pubmed">34836924</ArticleId></ArticleIdList></Reference><Reference><Citation>Terai H, Ishii M, Takemura R, et&#xa0;al. Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study. Respir Investig. 2023;61(6):802&#x2010;814.</Citation><ArticleIdList><ArticleId IdType="pubmed">37783167</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronsson G, Gustafsson K, Dallner M. Sick but yet at work. An empirical study of sickness presenteeism. J Epidemiol Community Health. 2000;54(7):502&#x2010;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1731716</ArticleId><ArticleId IdType="pubmed">10846192</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T, Miyaki K, Sasaki Y, et&#xa0;al. Optimal cutoff values of WHO&#x2010;HPQ presenteeism scores by ROC analysis for preventing mental sickness absence in Japanese prospective cohort. PLoS One. 2014;9(10):e111191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4207778</ArticleId><ArticleId IdType="pubmed">25340520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler RC, Barber C, Beck A, et&#xa0;al. The World Health Organization health and work performance questionnaire (HPQ). J Occup Environ Med. 2003;45(2):156&#x2010;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">12625231</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID&#x2010;19 in a large Norwegian cohort. Eur J Epidemiol. 2022;37(5):539&#x2010;548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi&#x2010;Pooya AA, Shahisavandi M, Nemati H, et&#xa0;al. Long&#x2010;lasting COVID&#x2010;associated brain fog: a follow&#x2010;up study. Eur Neurol. 2023;86(3):166&#x2010;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">36843124</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Johnsen S, Sattler SM, et&#xa0;al. Cognitive impairments four months after COVID&#x2010;19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39&#x2010;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordvig AS, Rajan M, Lau JD, et&#xa0;al. Brain fog in long COVID limits function and health status, independently of hospital severity and preexisting conditions. Front Neurol. 2023;14:1150096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10213727</ArticleId><ArticleId IdType="pubmed">37251229</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Lu S, Chen J, et&#xa0;al. The landscape of cognitive function in recovered COVID&#x2010;19 patients. J Psychiatr Res. 2020;129:98&#x2010;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado&#x2010;Alonso C, Diez&#x2010;Cirarda M, Pagan J, et&#xa0;al. Unraveling brain fog in post&#x2010;COVID syndrome: relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms. Eur J Neurol. 2023 Oct 5.</Citation><ArticleIdList><ArticleId IdType="pubmed">37797297</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez&#x2010;de&#x2010;Las&#x2010;Penas C, Cancela&#x2010;Cilleruelo I, Rodriguez&#x2010;Jimenez J, et&#xa0;al. Trajectory of post&#x2010;COVID brain fog, memory loss, and concentration loss in previously hospitalized COVID&#x2010;19 survivors: the LONG&#x2010;COVID&#x2010;EXP multicenter study. Front Hum Neurosci. 2023;17:1259660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10665893</ArticleId><ArticleId IdType="pubmed">38021227</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Bae S, Chang HH, Kim SW. Long COVID prevalence and impact on quality of life 2&#x2009;years after acute COVID&#x2010;19. Sci Rep. 2023;13(1):11207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10336045</ArticleId><ArticleId IdType="pubmed">37433819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Laksono BM, de Vrij FMS, Kushner SA, Harschnitz O, van Riel D. The neuroinvasiveness, neurotropism, and neurovirulence of SARS&#x2010;CoV&#x2010;2. Trends Neurosci. 2022;45(5):358&#x2010;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple AC, Oddi A, Peluso MJ, et&#xa0;al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID&#x2010;19. Ann Clin Transl Neurol. 2022;9(2):221&#x2010;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, et&#xa0;al. Blood&#x2010;brain barrier disruption and sustained systemic inflammation in individuals with long COVID&#x2010;associated cognitive impairment. Nat Neurosci. 2024;27(3):421&#x2010;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Scuffham PA, Vecchio N, Whiteford HA. Exploring the validity of HPQ&#x2010;based presenteeism measures to estimate productivity losses in the health and education sectors. Med Decis Mak. 2014;34(1):127&#x2010;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">23913916</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatys&#x2010;Bogacka Z, Mazurkiewicz I, Slowik J, et&#xa0;al. Brain fog and quality of life at work in non&#x2010;hospitalized patients after COVID&#x2010;19. Int J Environ Res Public Health. 2022;19(19):12816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9564568</ArticleId><ArticleId IdType="pubmed">36232113</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>